EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study

Steven J Steiner iD, Jeremy Adler, Shehzad A Saeed, Richard S Strauss, Kristin M Howe, Anna Sheahan, Renping Zhang, Kimberly R Keihn, Katharine Harrow, Kelly K Olano, David A Evans, Kim Hung Lo und 5 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2026-05 · 82 (5) · 1242-1250

DOI: 10.1002/jpn3.70372 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 02.03.2026. Verfasst von Steven J Steiner und 16 weiteren Autor:innen. Beteiligte Einrichtung: Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Crohn Disease, Ustekinumab. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Few approved treatments exist for children with Crohn's disease (CD). The REALITI study retrospectively assessed the effectiveness and safety of ustekinumab in real‐world clinical settings for children with CD.

Methods

Data were collected from the prospective ImproveCareNow (ICN) registry for pediatric patients (≥ 2 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseUstekinumabAdolescentAdultChildChild, PreschoolFemaleHumansMaleYoung AdultRegistriesRemission InductionRetrospective StudiesSeverity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

biologic productchildreninflammatory bowel diseasereal‐worldregistries

Substanzen

Ustekinumab

Autor:innen und Institutionen

  • Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • C.S. Mott Children's Hospital, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Dayton Children's Hospital/Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA.
  • Johnson & Johnson, Spring House, Pennsylvania, USA.
  • ImproveCareNow, Essex Junction, Vermont, USA.
  • Johnson & Johnson, Horsham, Pennsylvania, USA.

ORCID-Profile: Steven J Steiner, Sheri Volger

Förderung

  • Johnson & Johnson

Zitieren

APA

Steiner, S. J., Adler, J., Saeed, S. A., Strauss, R. S., Howe, K. M., Sheahan, A., Zhang, R., Keihn, K. R., Harrow, K., Olano, K. K., Evans, D. A., Lo, K. H., Zhang, N., Kim, L., Colletti, R. B., Volger, S., & ImproveCareNow Learning Health Network (2026). Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study. Journal of Pediatric Gastroenterology and Nutrition, 82(5), 1242-1250. https://doi.org/10.1002/jpn3.70372

Vancouver

Steiner SJ, Adler J, Saeed SA, Strauss RS, Howe KM, Sheahan A, et al. Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study. Journal of Pediatric Gastroenterology and Nutrition. 2026;82(5):1242-1250. doi:10.1002/jpn3.70372

BibTeX
@article{Steiner2026,
  author = {Steiner, Steven J and Adler, Jeremy and Saeed, Shehzad A and Strauss, Richard S and Howe, Kristin M and Sheahan, Anna and Zhang, Renping and Keihn, Kimberly R and Harrow, Katharine and Olano, Kelly K and Evans, David A and Lo, Kim Hung and Zhang, Nanhua and Kim, Lilianne and Colletti, Richard B and Volger, Sheri and ImproveCareNow Learning Health Network, ImproveCareNow Learning Health Network},
  title = {Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  volume = {82},
  number = {5},
  pages = {1242--1250},
  doi = {10.1002/jpn3.70372}
}
Kostenlos starten →